Biodegradable tissue filler and preparation method of porous polyester microspheres
By preparing biodegradable porous polyester microspheres, the poor cell penetration and industrial preparation problems caused by solid microsphere structure are solved, and the uniform growth of cells and collagen regeneration in the porous structure are achieved, the production process is simplified, and the production process is enhanced. The ability to regenerate cells and the effect of fillers.
Patent Information
- Application Number
- CN202411067993.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-06
- Publication Date
- 2024-11-22
AI Technical Summary
Existing solid microspheres degrade slowly in structure, resulting in cells being unable to pass through and forming continuous and uniform regenerated collagen. Their industrial preparation is complex and difficult to control pore size, porosity and connectivity.
Using biodegradable porous polyester microspheres, through the through-type and partially through-type porous structure, combined with thickeners, excipients and nutrients, lyophilized and wet heat sterilization treatment, the particle size is 100- Porous microspheres with a porosity of 20-99% are used as tissue fillers.
The uniform growth of cells in the porous structure and collagen regeneration are achieved, the adhesion and proliferation ability of regenerated cells is enhanced, and the channels for nutrient transportation and waste removal are provided, and the industrial production of porous microspheres is simplified.
Smart Images

Figure CN118987340A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biomedical materials, and in particular to a preparation method of a biodegradable tissue filler and porous polyester microspheres. Background Art
[0002] With the development of biomaterials science and clinical medicine technology, the plastic surgery industry has shifted from surgical beauty to minimally invasive non-surgical beauty, which has promoted the rapid development of minimally invasive injection beauty products and provided some beauty methods with less trauma and quick recovery.
[0003] At present, conventional tissue filling products include hyaluronic acid, collagen, hydroxyapatite and autologous fat particles, etc. These products have good filling effects and certain biocompatibility. However, the degradation cycle of conventional hyaluronic acid and collagen is relatively short. Although the degradation time can be extended by cross-linking, if the degree of cross-linking is large, there is a safety risk of cross-linking agent residue.
[0004] With the development of regenerative medicine, people are not satisfied with simple physical filling for medical and aesthetic filling materials. They not only require the materials to have excellent physical and chemical properties and reliable biosafety, but also require the materials to be able to induce the self-repair and regeneration of human tissues. At present, the patent with publication number CN113769164B introduces a polycaprolactone microsphere and its preparation method and use, and the patent with publication number CN105879124B introduces an injectable L-polylactic acid filler and its preparation method. Their common feature is that they are all solid polyester microspheres.
[0005] Structurally, solid microspheres degrade slowly, and cells cannot pass through the microspheres to form continuous and uniform regenerated collagen. Microspheres with porous structures can achieve uniform cell growth and collagen regeneration, but the process of porous microspheres is complex, industrial preparation is relatively difficult, and the pore size, porosity and inter-pore connectivity are difficult to control.
[0006] Therefore, it is a technical problem that urgently needs to be solved in this field to develop a simple, efficient, easy to regulate microsphere structure and high-yield production process, provide a biodegradable porous microsphere tissue filler to achieve industrial preparation of porous microspheres, and avoid the inability to continuously and uniformly generate regenerated collagen. Summary of the invention
[0007] The present invention provides a biodegradable tissue filler and a method for preparing porous polyester microspheres, which solves the technical problem that the regenerated collagen produced by solid microspheres cannot be continuously and uniformly generated.
[0008] The inventors have discovered through experiments that porous microspheres have through holes that are conducive to the entry of cells and gradually form a microenvironment for cell proliferation. Under the guidance of the microporous structure, a regenerated collagen network structure is formed to achieve a more natural repair effect. However, the preparation process of porous microspheres is complex and difficult to industrialize.
[0009] The defects existing in the above solutions are the results obtained by the inventor after practice and careful research. Therefore, the discovery process of the above problems and the solutions proposed by the present disclosure for the above problems below should be the contributions made by the inventor to the present disclosure during the disclosure process.
[0010] In order to solve the above technical problems, the present invention provides a biodegradable tissue filler, comprising: porous polyester microspheres, a thickener, an excipient, an anesthetic and a nutrient; wherein the porous polyester microspheres are microspheres with a pore structure prepared from a biodegradable polymer polyester; the pore structure is a through-type porous structure and a partially through-type porous structure; the particle size of the porous polyester microspheres is 100-500 microns, and the porosity is 20-99%; the mass percentage of the porous polyester microspheres in the porous polyester microsphere tissue filler is 1-60%.
[0011] Furthermore, the biodegradable polymer polyester includes any one or a combination of polylactic acid, polycaprolactone, polydioxanone, polyhydroxyalkanoate, polybutylene succinate, polylactic acid-glycolic acid copolymer and polylactic acid-ethylene glycol copolymer; wherein the molecular weight of the biodegradable polymer polyester is 10,000-500,000.
[0012] Furthermore, the thickener is any one of a natural polymer thickener and a cellulose thickener; the natural polymer thickener includes any one or more combinations of hyaluronic acid and its salt form, soluble starch, gum arabic, pectin, agar, gelatin and trehalose; the cellulose thickener includes any one or more combinations of carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose and methyl cellulose; the excipient includes any one or more combinations of mannitol, glucose, dextran and sorbitol; the anesthetic includes any one or more combinations of lidocaine, procaine, tetracaine, ropivacaine and bupivacaine; the nutritional ingredients include any one or more combinations of amino acids, nicotinamide, nicotinamide adenine dinucleotide, polypeptides, proteins, polysaccharides, polyols, vitamins and lipids.
[0013] In another aspect, the present invention further provides a method for preparing the biodegradable tissue filler as described above, wherein the tissue filler is in the form of a lyophilized powder, comprising the following steps: step S11, dissolving and mixing the pre-prepared porous polyester microspheres with a thickener, an excipient, an anesthetic and nutrients in an aqueous phase system in a certain proportion, and then putting them into a vial and removing moisture by freeze drying to obtain a solid filler; step S12, sterilizing the solid filler obtained in step S11 by irradiation or ethylene oxide to obtain a lyophilized powder tissue filler; wherein the aqueous phase system comprises any one of water for injection, physiological saline and phosphate buffer.
[0014] In a third aspect, the present invention further provides a method for preparing the biodegradable tissue filler as described above, wherein the dosage form of the tissue filler is a prefilled syringe type, comprising the following steps: step S21, dissolving and mixing the pre-prepared porous polyester microspheres with a thickener, an excipient, an anesthetic and a nutrient in an aqueous phase system in a certain proportion, and then loading the mixture into a prefilled syringe; step S22, sterilizing the prefilled syringe obtained in step S21 by wet heat sterilization to obtain a prefilled syringe type tissue filler; wherein the aqueous phase system comprises any one of water for injection, physiological saline and phosphate buffer.
[0015] In a fourth aspect, the present invention also provides a method for preparing the porous polyester microspheres as described above, wherein the porous polyester microspheres are microspheres with a through-type porous structure, comprising the following steps: step S31, pouring 20 mL of an organic phase containing 0.5-10 g of a biodegradable polymer polyester dissolved in 1-10 mL of a 0.1-10% porogen aqueous solution, stirring at 100-10000 rpm, and controlling the temperature in an ice water bath to obtain colostrum; step S32, pouring the colostrum into a 0.1-10% surfactant aqueous solution and stirring to obtain a double emulsion; step S33, subjecting the double emulsion to a temperature treatment, removing the organic phase and the porogen, and solidifying the microspheres, washing, filtering and collecting the porous microspheres with an average particle size of 100-500 μm and a porosity of 20-99%, and placing them in a 0.1-10 M sodium hydroxide solution for hydrolysis, and then washing, filtering and collecting with running water to obtain porous polyester microspheres with a through-type porous structure.
[0016] Furthermore, the porogen is a temperature-sensitive substance; the organic phase includes any one or more combinations of dichloromethane, chloroform, ethyl acetate, acetone and methanol; the surfactant includes any one or more combinations of polyvinyl alcohol, disodium lauryl sulfosuccinate, potassium monododecyl phosphate, sodium dodecylbenzene sulfonate, Span 80 and gelatin; and the set temperature of the temperature increase treatment is higher than the boiling point of the organic phase.
[0017] In a fifth aspect, the present invention also provides a method for preparing the porous polyester microspheres as described above, wherein the porous polyester microspheres are microspheres with a partially penetrating porous structure, comprising the following steps: S41, pouring inorganic matter into 20 mL of an organic phase in which 0.5-10 g of a biodegradable high molecular weight polyester is dissolved, stirring at 100-10000 rpm and pouring in a 0.1-10% surfactant aqueous solution and stirring to obtain an emulsion; step S42, subjecting the emulsion to a temperature treatment, removing the organic phase, and solidifying the microspheres, washing, filtering and collecting microspheres with an average particle size of 100-500 μm, and placing an inorganic matter removal solution to etch the inorganic matter on the surface of the microspheres, followed by washing, filtering and collecting with running water, to finally obtain porous polyester microspheres with a partially penetrating porous structure with a porosity of 20-99%.
[0018] Furthermore, the inorganic substance includes any one or more combinations of calcium carbonate, hydroxyapatite, calcium oxalate, calcium silicate, calcium phosphate, calcium tartrate, magnesium carbonate and magnesium oxide; the inorganic substance removal solution includes any one of ethylenediaminetetraacetic acid, acid solution and alkaline solution; the concentration of the acid solution is 0.1 to 12 mol / L; the concentration of the alkaline solution is 0.1 to 10 mol / L.
[0019] In a sixth aspect, the present invention further provides a use of the biodegradable tissue filler as described above or the biodegradable tissue filler prepared by the method as described above in the field of medical cosmetic wrinkle correction and tissue filling.
[0020] The beneficial effects of the present invention are that the preparation method of the biodegradable tissue filler and porous polyester microspheres of the present invention uses biodegradable porous polyester microspheres as tissue regeneration scaffolds, and utilizes their high interconnectivity to enable cells to be more effectively and continuously and evenly generated in the porous structure, while also providing a surface area for the transportation of nutrients and the removal of waste, thereby enhancing the adhesion and proliferation ability of regenerated cells. In addition, the porous structure also provides a wrapping and protection function for the newborn cells to avoid physical damage; in addition, the through-type porous structure prepared by the multiple emulsification method and the partially through-type porous structure prepared by the etching method both provide a simpler and more efficient method for the industrial production of porous microspheres in tissue fillers.
[0021] Other features and advantages of the present invention will be described in the following description, and partly become apparent from the description, or understood by practicing the present invention. The purpose and other advantages of the present invention are realized and obtained by the structures particularly pointed out in the description and the drawings.
[0022] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, preferred embodiments are given below and described in detail with reference to the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0024] Figure 1 is a SEM morphology image of the polyester microspheres prepared in Example 1 of the present invention;
[0025] Figure 2 is an electron microscope image of the porous polyester microspheres prepared in Example 1 of the present invention;
[0026] Figure 3 The porous polyester microsphere tissue filler prepared in Example 1 of the present invention;
[0027] Figure 4 is an electron microscope image of the porous polyester microspheres prepared in Example 2 of the present invention;
[0028] Figure 5 is a SEM morphology image of the porous polyester microspheres prepared in Example 5 of the present invention;
[0029] Figure 6 The porous polyester microsphere tissue filler prepared in Example 2 of the present invention;
[0030] Figure 7 is a SEM morphology image of the porous polyester microspheres prepared in Example 6 of the present invention;
[0031] Figure 8 is a morphology comparison diagram of the porous polyester microspheres prepared in Example 2 of the present invention before hydrolysis;
[0032] Fig. 9 is a comparison diagram of the morphology of the porous polyester microspheres prepared in Example 2 of the present invention after hydrolysis;
[0033] Fig.10 is a particle size distribution diagram of porous polyester microspheres in Example 1 of the present invention;
[0034] Fig.11 This is a HE staining result of the freeze-dried sample containing porous polyester microspheres in Example 1 of the present invention implanted subcutaneously in mice for 0.5 months;
[0035] Fig.12 This is a HE staining result of the freeze-dried sample containing porous polyester microspheres in Example 1 of the present invention implanted subcutaneously in mice one month later;
[0036] Fig.13This is a HE staining result of the freeze-dried sample containing porous polyester microspheres in Example 1 of the present invention implanted subcutaneously in mice for 3 months;
[0037] Fig.14 This is a diagram showing the inflammatory effect of the freeze-dried solid polyester microsphere sample implanted subcutaneously in mice in Comparative Example 1 of the present invention;
[0038] Fig.15 These are the in vitro degradation results of the polyester microspheres in Examples 1, 2, 6 and Comparative Example 1 of the present invention under alkaline conditions. DETAILED DESCRIPTION
[0039] In order to make the purpose, technical solution and advantages of the embodiments of the present invention clearer, the technical solution of the present invention will be clearly and completely described below in conjunction with the accompanying drawings. Obviously, the described embodiments are part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0040] At least one embodiment provides a biodegradable tissue filler, comprising: porous polyester microspheres, a thickener, an excipient, an anesthetic and a nutrient; wherein the porous polyester microspheres are microspheres with a pore structure made of biodegradable polymer polyester; the pore structure is a through-type porous structure and a partially through-type porous structure; the porous polyester microspheres have a particle size of 100-500 microns and a porosity of 20-99%; the mass percentage of the porous polyester microspheres in the porous polyester microsphere tissue filler is 1-60%.
[0041] In some embodiments, specifically, the biodegradable polymer polyester includes any one or a combination of polylactic acid, polycaprolactone, polydioxanone, polyhydroxyalkanoate, polybutylene succinate, polylactic acid-glycolic acid copolymer and polylactic acid-ethylene glycol copolymer; wherein the molecular weight of the biodegradable polymer polyester is 10,000-500,000.
[0042] In some embodiments, specifically, the thickener is any one of a natural polymer thickener and a cellulose thickener; the natural polymer thickener includes any one or more of hyaluronic acid and its salt form, soluble starch, gum arabic, pectin, agar, gelatin and trehalose; the cellulose thickener includes any one or more of carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose and methyl cellulose; the excipient includes any one or more of mannitol, glucose, dextran and sorbitol; the anesthetic includes any one or more of lidocaine, procaine, tetracaine, ropivacaine and bupivacaine; the nutritional ingredients include any one or more of amino acids, nicotinamide, nicotinamide adenine dinucleotide, polypeptides, proteins, polysaccharides, polyols, vitamins and lipids.
[0043] At least one embodiment provides a method for preparing the biodegradable tissue filler as described above, wherein the dosage form of the tissue filler is a lyophilized powder, comprising the following steps: step S11, dissolving and mixing the pre-prepared porous polyester microspheres with a thickener, an excipient, an anesthetic and nutrients in an aqueous phase system in a certain proportion, and then putting them into a vial and removing moisture by freeze drying to obtain a solid filler; step S12, sterilizing the solid filler obtained in step S11 by irradiation or ethylene oxide to obtain a lyophilized powder tissue filler; wherein the aqueous phase system comprises any one of water for injection, physiological saline and phosphate buffer.
[0044] At least one embodiment provides a method for preparing the biodegradable tissue filler as described above, wherein the dosage form of the tissue filler is a prefilled syringe type, comprising the following steps: step S21, dissolving and mixing the pre-prepared porous polyester microspheres with a thickener, an excipient, an anesthetic and a nutrient in an aqueous phase system in a certain proportion, and then loading the mixture into a prefilled syringe; step S22, sterilizing the prefilled syringe obtained in step S21 by wet heat sterilization to obtain a prefilled syringe type tissue filler; wherein the aqueous phase system comprises any one of water for injection, physiological saline and phosphate buffer.
[0045] At least one embodiment provides a method for preparing the porous polyester microspheres as described above, wherein the porous polyester microspheres are microspheres with a through-type porous structure, comprising the following steps: step S31, pouring 20 mL of an organic phase in which 0.5-10 g of a biodegradable polymer polyester is dissolved into 1-10 mL of a 0.1-10% porogen aqueous solution, stirring at 100-10000 rpm, and controlling the temperature in an ice water bath to obtain colostrum; step S32, pouring the colostrum into a 0.1-10% surfactant aqueous solution and stirring to obtain a double emulsion; step S33, subjecting the double emulsion to a temperature treatment, removing the organic phase and the porogen, and solidifying the microspheres, washing, filtering and collecting the porous microspheres with an average particle size of 100-500 μm and a porosity of 20-99%, and placing them in a 0.1-10 M sodium hydroxide solution for hydrolysis, and then washing, filtering and collecting with running water to obtain porous polyester microspheres with a through-type porous structure.
[0046] In some embodiments, specifically, the porogen is a temperature-sensitive substance, that is, it can change its properties when the temperature changes. For example, when ammonium bicarbonate is used as a porogen, it can be decomposed into gas after heating and then removed to form a pore structure; when gelatin is used as a porogen, it can be changed from a non-fluid gel to a flowable thin liquid after heating, and then removed to form a pore structure; the organic phase includes any one or more of dichloromethane, chloroform, ethyl acetate, acetone and methanol; the surfactant includes any one or more of polyvinyl alcohol, disodium lauryl sulfosuccinate, potassium monododecyl phosphate, sodium dodecylbenzene sulfonate, Span 80 and gelatin; the set temperature of the heating treatment is higher than the boiling point of the organic phase to accelerate the discharge of the organic solvent from the microspheres.
[0047] At least one embodiment provides a method for preparing the porous polyester microspheres as described above, wherein the porous polyester microspheres are microspheres with a partially penetrating porous structure, comprising the following steps: S41, pouring inorganic matter into 20 mL of an organic phase in which 0.5-10 g of a biodegradable high molecular weight polyester is dissolved, stirring at 100-10000 rpm and pouring in a 0.1-10% surfactant aqueous solution and stirring to obtain an emulsion; step S42, subjecting the emulsion to a temperature treatment, removing the organic phase, and solidifying the microspheres, washing, filtering and collecting microspheres with an average particle size of 100-500 μm, and placing an inorganic matter removal solution to etch the inorganic matter on the surface of the microspheres, followed by washing, filtering and collecting with running water, to finally obtain porous polyester microspheres with a partially penetrating porous structure with a porosity of 20-99%.
[0048] In some embodiments, specifically, the inorganic substance includes any one or more combinations of calcium carbonate, hydroxyapatite, calcium oxalate, calcium silicate, calcium phosphate, calcium tartrate, magnesium carbonate and magnesium oxide; the inorganic substance removal solution includes any one of ethylenediaminetetraacetic acid, acid solution and alkaline solution; the concentration of the acid solution is 0.1 to 12 mol / L; the concentration of the alkaline solution is 0.1 to 10 mol / L.
[0049] Example 1
[0050] Pour 5 mL of 1% ammonium bicarbonate aqueous solution into 20 mL of dichloromethane dissolved with 2 g of polylactic acid, stir at 2000 rpm, and control the temperature in an ice-water bath to obtain colostrum. Then pour the colostrum into a 1% polyvinyl alcohol aqueous solution and stir to obtain a double emulsion. After heating treatment, the dichloromethane and ammonium bicarbonate are removed, and the microspheres are solidified. The porous microspheres with an average particle size of 200 μm and a porosity of 90% are washed, filtered, and collected, and placed in a 0.1 M sodium hydroxide solution for hydrolysis, and then washed, filtered, and collected with running water to finally obtain microspheres with a through-type porous structure; 4% of porous microspheres, 3% sodium carboxymethyl cellulose, 3% mannitol, protein, lidocaine and the remaining water are stirred and mixed evenly. After mixing, fill in a vial, freeze-dry, and sterilize by irradiation to obtain the following Figure 3 A biodegradable porous polylactic acid microsphere tissue filler is shown.
[0051] Example 2
[0052] Pour 1 mL of 7.5% gelatin aqueous solution into 20 mL of chloroform dissolved with 10 g of polycaprolactone, stir at 10,000 rpm, and control the temperature in an ice-water bath to obtain colostrum. Then pour the colostrum into a 4% disodium lauryl sulfosuccinate aqueous solution and stir to obtain a double emulsion. After heating treatment, the chloroform and gelatin are removed, and the microspheres are solidified. The porous microspheres with an average particle size of 200 μm and a porosity of 99% are washed, filtered, and collected, and placed in a 0.5 M sodium hydroxide solution for hydrolysis, then washed, filtered, and collected with running water to finally obtain microspheres with a through-type porous structure; 10% of the porous microspheres, 1% of sodium hyaluronate, niacinamide, procaine and the remaining water are stirred and mixed evenly. After mixing, fill in a prefilled syringe and sterilize with high pressure and wet heat to obtain the following. Figure 6 A biodegradable porous polycaprolactone microsphere tissue filler is shown.
[0053] Example 3
[0054] Pour 10 mL of 10% ammonium bicarbonate aqueous solution into 20 mL of acetone in which 8 g of polydioxanone is dissolved, stir at 8000 rpm, and control the temperature in an ice water bath to obtain colostrum. Then pour the colostrum into a 6% potassium monododecyl phosphate aqueous solution and stir to obtain a double emulsion. After heating treatment, remove the acetone and ammonium bicarbonate, solidify the microspheres, wash, filter and collect the porous microspheres with an average particle size of 300 μm, put them into a 5M sodium hydroxide solution for hydrolysis, wash, filter and collect them with running water, and finally obtain microspheres with a porosity of 80% and a through-type porous structure; stir and mix 1% of porous microspheres, 40% of soluble starch, 40% of mannitol, amino acids, tetracaine and the remaining water. After mixing, fill them in a vial, freeze-dry and sterilize them by irradiation to obtain a biodegradable porous polydioxanone microsphere tissue filler.
[0055] Example 4
[0056] 2.5 mL of 0.1% gelatin aqueous solution is poured into 20 mL of ethyl acetate dissolved with 0.5 g of polyhydroxyalkanoate, stirred at 4000 rpm, and controlled by ice water bath to obtain colostrum. Then the colostrum is poured into 0.1% gelatin aqueous solution and stirred to obtain a double emulsion. After heating treatment, the ethyl acetate and gelatin are removed, and the microspheres are solidified, washed, filtered and collected, and porous microspheres with an average particle size of 500 μm are washed, filtered and collected, and then put into 10M sodium hydroxide solution for hydrolysis, washed, filtered and collected with running water, and finally microspheres with a porosity of 60% and a through-type porous structure are obtained; 20% of porous microspheres, 50% of hydroxyethyl cellulose, 20% of dextran, lipids, ropivacaine and the remaining water are stirred and mixed uniformly. After mixing, they are filled in a vial, freeze-dried and sterilized by irradiation to obtain a biodegradable porous polyhydroxyalkanoate microsphere tissue filler.
[0057] Example 5
[0058] 200 mg of calcium carbonate is poured into 20 mL of methanol in which 4 g of polylactic acid-glycolic acid copolymer is dissolved, stirred at 100 rpm and poured into 0.5% sodium dodecylbenzene sulfonate aqueous solution for stirring to obtain an emulsion. After heating treatment, the methanol is removed, and the microspheres are solidified, washed, filtered and collected, and the microspheres with an average particle size of 400 μm are washed, filtered and collected, and 10% ethylenediaminetetraacetic acid solution is added to etch the calcium carbonate on the surface of the microspheres, and then washed, filtered and collected with running water, and finally a microsphere with a porosity of 40% and a partially through-type porous structure is obtained; 60% of the porous microspheres, 20% of sodium alginate, 10% of glucose, polypeptide, bupivacaine and the remaining water are stirred and mixed evenly. After mixing, it is filled in a vial, and after freeze-drying, irradiation sterilization is used to obtain a biodegradable porous polylactic acid-glycolic acid copolymer microsphere tissue filler.
[0059] Example 6
[0060] 200 mg of magnesium carbonate is poured into a mixed solution of dichloromethane and ethyl acetate in which 6 g of polylactic acid-ethylene glycol copolymer is dissolved in 20 mL, stirred at 500 rpm and poured into a 10% Span 80 aqueous solution for stirring to obtain an emulsion. After heating treatment, dichloromethane and ethyl acetate are removed, and the microspheres are solidified, washed, filtered and collected, and the microspheres with an average particle size of 100 μm are washed, filtered and collected, and a 12M hydrochloric acid solution is placed to etch the magnesium carbonate on the surface of the microspheres, and then washed, filtered and collected with running water, and finally a microsphere with a porosity of 20% and a partially through-type porous structure is obtained; 30% of porous microspheres, 10% of hydroxypropyl methylcellulose, 50% of sorbitol, vitamins, lidocaine and the remaining water are stirred and mixed uniformly. After mixing, it is filled in a cillin bottle, and after freeze-drying, irradiation sterilization is used to obtain a biodegradable porous polylactic acid-ethylene glycol copolymer microsphere tissue filler.
[0061] Comparative Example 1
[0062] 20 mL of dichloromethane containing 2 g of polylactic acid was poured into a 1% polyvinyl alcohol aqueous solution and stirred at 2000 rpm to obtain an emulsion. After heating treatment, the dichloromethane was removed to solidify the microspheres, and the microspheres were washed with running water, filtered and collected to finally obtain solid microspheres with an average particle size of 100 μm; 4% of porous microspheres, 3% of sodium carboxymethyl cellulose, 3% of mannitol, protein, lidocaine and the remaining water were stirred and mixed evenly. After mixing, the microspheres were filled in vials, and lyophilized and sterilized by irradiation to obtain a biodegradable porous polylactic acid microsphere tissue filler.
[0063] See also Figure 1-2 , Figure 4-5 and Figure 7 ,like Figure 1 , 2 As shown in Figures 4, 5 and 7, the porous polyester microspheres in some embodiments have through-hole and partially through-hole structural characteristics.
[0064] See also Figure 8-9 ,like Figure 8 , 9 As shown, hydrolysis can open the pores on the surface of porous microspheres, which is conducive to cell entry.
[0065] See also Fig.10 ,like Fig.10 As shown, the porous polyester microspheres in some embodiments have a narrow particle size distribution, indicating that the preparation method is stable and reliable.
[0066] See also Fig.11 ,like Fig.11As shown, the HE staining results of the freeze-dried sample containing porous polyester microspheres in Example 1 were implanted subcutaneously in mice for 0.5 months; it showed that the cell density outside the porous microspheres was greater than that inside, and the cells had gradually grown from the surface into the microspheres. The white unstained area inside the microspheres was the location of the polyester microspheres and the cavities; the number of microspheres was relatively large.
[0067] In some embodiments, specifically, microspheres and porous microspheres all refer to porous polyester microspheres.
[0068] See also Fig.12 ,like Fig.12 As shown, the HE staining results of the freeze-dried sample containing porous polyester microspheres in Example 1 were implanted subcutaneously in mice one month later; it showed that the cell density inside the porous microspheres was relatively uniform, the cells almost filled the inside of the microspheres, and the white unstained area inside the microspheres was the location of the polyester microspheres; the number of microspheres was still relatively large.
[0069] See also Fig.13 ,like Fig.13 As shown, the HE staining results of the freeze-dried sample containing porous polyester microspheres in Example 1 were implanted subcutaneously in mice for 3 months; it showed that the cells still filled the inside of the microspheres, and the white unstained area inside the microspheres was the location of the polyester microspheres; but as the cells degraded the microspheres, the number of microspheres decreased.
[0070] See also Fig.14 ,like Fig.14 As shown, the inflammatory effect diagram of the solid polyester microsphere freeze-dried sample in Comparative Example 1 after being implanted subcutaneously in mice; it shows that cells grow around the surface of the microspheres, and the white undyed area inside the microspheres is the location of the polyester microspheres, and the microspheres can only be gradually degraded from the outside.
[0071] like Fig.11 and Fig.14 By comparison, compared with solid microspheres, porous microspheres have through holes that are conducive to cell entry and gradually form a microenvironment for cell proliferation. Under the guidance of the microporous structure, a regenerated collagen network structure is formed, achieving a more natural repair effect and realizing true tissue engineering regeneration.
[0072] like Fig.15 As shown in Table 1 below, polyester microspheres of different materials and different molecular weights have different degradation rates under alkaline conditions, but in general, porous microspheres degrade faster than solid microspheres.
[0073] Table 1
[0074] Degradation rate 0h 6h 12h 24h 48h Example 1 0% 31% 52% 81% 100% Example 2 0% 28% 44% 76% 100% Example 6 0% 39% 51% 83% 100% Comparative Example 1 0% 26% 41% 72% 100%
[0075] Figure 11-13As shown in the figure, after the porous microspheres are implanted subcutaneously, as time goes by, the cells first gradually grow into the microspheres, and then slowly hydrolyze the microsphere structure, indicating that it has excellent degradable properties. After being implanted in the body, the porous microspheres can effectively stimulate the inflammatory response, and then stimulate the body to produce collagen fibers, effectively achieving tissue regeneration at the wrinkles, and in the gradual decomposition process in the body, the final degradation products are CO2 and H2O, and the intermediate product lactic acid is also a normal component in the body. Therefore, polylactic acid will not have adverse effects on the organism after degradation in the organism, and has significant biological safety.
[0076] In summary, the biodegradable tissue filler and the preparation method of porous polyester microspheres of the present invention use biodegradable porous polyester microspheres as tissue regeneration scaffolds, and utilize their high interconnectivity to enable cells to be more effectively and continuously and evenly generated in the porous structure, while also providing a surface area for the transportation of nutrients and the removal of waste, thereby enhancing the adhesion and proliferation ability of regenerated cells. In addition, the porous structure also provides a wrapping and protection function for the new cells to avoid physical damage; in addition, the through-type porous structure prepared by the multiple emulsification method and the partially through-type porous structure prepared by the etching method both provide a simpler and more efficient method for the industrial production of porous microspheres in tissue fillers.
[0077] Based on the above ideal embodiments of the present invention, the relevant staff can make various changes and modifications without departing from the technical concept of the present invention through the above description. The technical scope of the present invention is not limited to the contents of the specification, and its technical scope must be determined according to the scope of the claims.
Claims
1. A biodegradable tissue filler, characterized in that: include: porous polyester microspheres, thickeners, excipients, anesthetics, and nutrients; in The porous polyester microspheres are microspheres with a pore structure made from biodegradable polymer polyester; The pore structure is a through-type porous structure and a partially through-type porous structure; The porous polyester microspheres have a particle size of 100-500 microns and a porosity of 20-99%; The mass percentage of the porous polyester microspheres in the porous polyester microsphere tissue filler is 1-60%.
2. The biodegradable tissue filler according to claim 1, characterized in that: The biodegradable polymer polyester includes any one or a combination of polylactic acid, polycaprolactone, polydioxanone, polyhydroxyalkanoate, polybutylene succinate, polylactic acid-glycolic acid copolymer and polylactic acid-ethylene glycol copolymer; wherein The molecular weight of the biodegradable high molecular weight polyester is 10,000-500,000.
3. The biodegradable tissue filler according to claim 1, characterized in that: The thickener is any one of a natural polymer thickener and a cellulose thickener; The natural polymer thickener includes any one or more combinations of hyaluronic acid and its salt form, soluble starch, gum arabic, pectin, agar, gelatin and trehalose; The cellulose thickener includes any one or more combinations of carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl methyl cellulose and methyl cellulose; The excipient includes any one or more combinations of mannitol, glucose, dextran and sorbitol; The anesthetic comprises any one or more combinations of lidocaine, procaine, tetracaine, ropivacaine and bupivacaine; The nutritional ingredients include any one or more combinations of amino acids, nicotinamide, nicotinamide adenine dinucleotide, polypeptides, proteins, polysaccharides, polyols, vitamins and lipids.
4. A method for preparing the biodegradable tissue filler according to any one of claims 1 to 3, characterized in that: The dosage form of the tissue filler is a lyophilized powder, comprising the following steps: Step S11, dissolving and mixing the pre-prepared porous polyester microspheres with a thickener, an excipient, an anesthetic and a nutrient in a water phase system in a certain proportion, and then putting them into a vial and removing water through freeze drying to obtain a solid filler; Step S12, sterilizing the solid filler obtained in step S11 by irradiation or ethylene oxide to obtain a freeze-dried powder tissue filler; wherein The aqueous phase system includes any one of water for injection, physiological saline and phosphate buffer.
5. A method for preparing the biodegradable tissue filler according to any one of claims 1 to 3, characterized in that: The dosage form of the tissue filler is a prefilled syringe type, comprising the following steps: Step S21, dissolving and mixing the pre-prepared porous polyester microspheres, thickener, excipient, anesthetic and nutrient in a water phase system in a certain proportion, and then loading into a pre-filled syringe; Step S22, sterilizing the prefilled syringe obtained in step S21 by wet heat sterilization to obtain a prefilled syringe-type tissue filler; wherein The aqueous phase system includes any one of water for injection, physiological saline and phosphate buffer.
6. A method for preparing porous polyester microspheres as claimed in claim 1, characterized in that: The porous polyester microspheres are microspheres with a through-type porous structure, comprising the following steps: Step S31, pouring 20 mL of an organic phase in which 0.5-10 g of a biodegradable high molecular weight polyester is dissolved into 1-10 mL of a 0.1-10% porogen aqueous solution, stirring at 100-10000 rpm, and controlling the temperature in an ice water bath to obtain colostrum; Step S32, pouring the colostrum into a 0.1-10% surfactant aqueous solution and stirring to obtain a double emulsion; Step S33, subjecting the emulsion to a temperature treatment, removing the organic phase and the porogen, and solidifying the microspheres, washing, filtering and collecting the porous microspheres with an average particle size of 100-500 μm and a porosity of 20-99%, and placing them in a 0.1-10 M sodium hydroxide solution for hydrolysis, and then washing, filtering and collecting with running water to obtain porous polyester microspheres with a through-hole porous structure.
7. The method for preparing porous polyester microspheres according to claim 6, characterized in that: The porogen is a temperature-sensitive substance; The organic phase includes any one or more of dichloromethane, chloroform, ethyl acetate, acetone and methanol; The surfactant includes any one or more combinations of polyvinyl alcohol, disodium lauryl sulfosuccinate, potassium monododecyl phosphate, sodium dodecylbenzene sulfonate, Span 80 and gelatin; The set temperature of the temperature increase treatment is higher than the boiling point of the organic phase.
8. A method for preparing porous polyester microspheres as claimed in claim 1, characterized in that: The porous polyester microspheres are microspheres with partially penetrating porous structures, comprising the following steps: S41, pouring the inorganic substance into 20 mL of an organic phase in which 0.5-10 g of a biodegradable high molecular weight polyester is dissolved, stirring at 100-10000 rpm and pouring in a 0.1-10% surfactant aqueous solution and stirring to obtain an emulsion; Step S42, subjecting the emulsion to a temperature treatment, removing the organic phase, and solidifying the microspheres, washing, filtering and collecting the microspheres with an average particle size of 100-500 μm, and placing them in an inorganic removal solution to etch the inorganic matter on the surface of the microspheres, and then washing, filtering and collecting them with running water, finally obtaining porous polyester microspheres with a partially penetrating porous structure with a porosity of 20-99%.
9. The method for preparing porous polyester microspheres according to claim 8, characterized in that: The inorganic substance includes any one or more combinations of calcium carbonate, hydroxyapatite, calcium oxalate, calcium silicate, calcium phosphate, calcium tartrate, magnesium carbonate and magnesium oxide; The inorganic substance removal solution includes any one of ethylenediaminetetraacetic acid, an acid solution and an alkaline solution; The concentration of the acid solution is 0.1-12 mol / L; the concentration of the alkali solution is 0.1-10 mol / L.
10. Use of the biodegradable tissue filler according to claims 1-3 or the biodegradable tissue filler prepared by the method according to claims 4-5 in the field of medical cosmetic wrinkle correction and tissue filling.
Citation Information
Cited By
Working solution flash dehydration system and method in process of preparing hydrogen peroxide by anthraquinone process
CN120607225A
A flash dehydration system and method for working solution in the anthraquinone process for hydrogen peroxide production.
CN120607225B
Application of surface heterogeneous microspheres in preparation of tissue filling product
CN121796682A
